|
|
| | Linagliptin Impurity D Basic information |
| Product Name: | Linagliptin Impurity D | | Synonyms: | tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate;Linagliptin Impurity 21;Linagliptin-4;(R)-tert-butyl (1-(7-(but-2-yn-1-yl);3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butoxycarbonylamino)piperidin-1-yl]xanthine;Carbamic acid,[(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester;Linagliptin impurity 4/Tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate;Carbamic acid, [(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI) | | CAS: | 666816-91-7 | | MF: | C20H28N6O4 | | MW: | 416.47 | | EINECS: | | | Product Categories: | | | Mol File: | 666816-91-7.mol |  |
| | Linagliptin Impurity D Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | pka | 9.38±0.70(Predicted) |
| | Linagliptin Impurity D Usage And Synthesis |
| Uses | 3-Methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tertbutyloxycarbonylamino)piperidin-1-yl]-xanthine is a useful synthetic compound. |
| | Linagliptin Impurity D Preparation Products And Raw materials |
|